pentoxifylline has been researched along with Coagulation Disorders, Blood in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Assimakopoulos, SF | 1 |
| Seintis, F | 1 |
| Marangos, M | 1 |
| Criado, PR | 1 |
| Alavi, A | 1 |
| Halpern, I | 1 |
| Sotto, MN | 1 |
| Kirsner, RS | 1 |
| Müller, R | 1 |
| Lebrach, F | 1 |
| Angelkort, B | 1 |
| Bahrami, S | 2 |
| Yao, YM | 1 |
| Shiga, H | 1 |
| Leichtfried, G | 1 |
| Redl, H | 2 |
| Schlag, G | 2 |
| Buurman, WA | 1 |
1 review available for pentoxifylline and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline.
Topics: Blood Coagulation; Blood Coagulation Disorders; Fibrinolytic Agents; Humans; Microcirculation; Pento | 1980 |
5 other studies available for pentoxifylline and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Pentoxifylline and complicated COVID-19: A pathophysiologically based treatment proposal.
Topics: Antibodies, Monoclonal, Humanized; Betacoronavirus; Blood Coagulation Disorders; Coronavirus Infecti | 2020 |
Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.
Topics: Adolescent; Aspirin; Biopsy; Blood Coagulation Disorders; Blood Coagulation Tests; Diagnosis, Differ | 2013 |
Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.
Topics: Adenosine Triphosphate; Arterial Occlusive Diseases; Blood Coagulation Disorders; Chronic Disease; E | 1981 |
Comparison of the efficacy of pentoxifylline and albifyllin (HWA 138) on endotoxin-induced cytokine production, coagulation disturbances, and mortality.
Topics: Animals; Antithrombin III; Blood Coagulation Disorders; Bronchodilator Agents; Cytokines; Dose-Respo | 1996 |
Influence of the xanthine derivate HWA 138 on endotoxin-related coagulation disturbances: effects in non-sensitized vs D-galactosamine sensitized rats.
Topics: Animals; Antithrombin III; Blood Coagulation Disorders; Blood Glucose; Fibrinogen; Galactosamine; He | 1992 |